Barbara Clorey
Physician Assistant · Washington, DCNPI 1073607669
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $815 and has fallen 74.2% since, to $210 in 2025. Among physician assistant clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$432
- AbbVie$343
- Exact Sciences$147
- Amarin Pharma, Inc.$120
- Genentech USA, Inc.$117
- Lilly USA, LLC$111
- plus $1K from 27 others
What the payments were for
- Food & beverage$2,379100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $432 |
| AbbVie | 22 | $343 |
| Exact Sciences | 7 | $147 |
| Amarin Pharma, Inc. | 6 | $120 |
| Genentech USA, Inc. | 6 | $117 |
| Lilly USA, LLC | 6 | $111 |
| Merck | 4 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $102 |
| Corcept Therapeutics | 4 | $91 |
| Pfizer | 6 | $90 |
| Astellas Pharma US Inc | 4 | $83 |
| Abbott | 5 | $78 |
| Boehringer Ingelheim | 5 | $76 |
| AstraZeneca | 5 | $73 |
| GSK | 3 | $42 |
| Philips North America LLC | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $35 |
| Kaleo, Inc. | 2 | $31 |
| Boston Scientific | 1 | $29 |
| Acerus Pharmaceuticals Corporation | 2 | $28 |
| Optinose US, Inc. | 2 | $27 |
| Bayer | 1 | $21 |
| TMS Neurohealth Centers Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Halozyme Inc | 1 | $14 |
| Novartis | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$2,390 in reported general payments places this provider in the 90th percentile of 372 physician assistant providers in District of Columbia.
See all physician assistant providers in District of Columbia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 38 | $1,108 |
| Atorvastatin Calcium | 49 | $464 |
| Losartan Potassium | 23 | $445 |
| Amlodipine Besylate | 29 | $413 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 17 | $382 |
| Levothyroxine Sodium | 23 | $259 |
| Metformin Hcl ErMetformin Hcl | 14 | $253 |
| Lisinopril | 20 | $244 |
| Metoprolol Succinate | 13 | $234 |
| Tamsulosin Hcl | 11 | $211 |
| Simvastatin | 13 | $167 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Washington
- Shana PermanWashington$36K
- Keriann KupermanWashington$24K
- Harleen BathWashington$18K
- Dustin FronczakWashington$13K
- Irena CulicWashington$13K
- Catherine UgliettaWashington$9K
- Milajurine LindsayWashington$9K
- Joseph HudsonWashington$8K
- Sonia BahrooWashington$7K
- Ryan WierWashington$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.